Literature DB >> 21900419

Factors associated with the seroprevalence of 26 cutaneous and two genital human papillomavirus types in organ transplant patients.

F Sampogna1, J N Bouwes Bavinck2, M Pawlita3, D Abeni1, C A Harwood4, C M Proby4, M C W Feltkamp5, S Euvrard6, L Naldi7, R E Neale8, I Nindl9, H Pfister10, W G V Quint11, T Waterboer3.   

Abstract

Viral skin infections are commonly present in organ transplant recipients (OTR). In this study, we aimed to identify factors associated with human papillomavirus (HPV) infections in OTR. Patients with solid-organ transplants were recruited from the outpatient nephrology and dermatology clinics in five European countries. Only patients with no current or past skin cancer were included in this analysis. Serum samples were analysed for antibodies to the L1 proteins of 26 cutaneous and two genital HPV types from five phylogenetic genera (α, β, γ, μ and ν). The most consistent association was found between recreational sun exposure and the seroprevalence of all tested genera, except α. The antibody presence of any β type was higher among people who had been transplanted at least 23 years prior to participation than in those who had been transplanted for less than 7 years. The prevalence of two γ-HPV types (60 and 65) and three β-HPV types (15, 38 and 49) was associated with time since transplantation. The presence of a high number of warts was associated with the presence of any μ-PV or ν-PV types, and having greater than 50 keratotic skin lesions was almost significantly associated with the presence of antibodies to two or more γ-PV. Discrepancies in the results of the present study, as well as in previous reports, may depend on different methodologies and on geographical variations. Our results also indicate that further research with more standardized methods is needed to clarify the role of cutaneous HPV in OTR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900419     DOI: 10.1099/vir.0.035493-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  Seroprevalence of cutaneous human papillomaviruses (HPVs) among men in the multinational HPV Infection in Men study.

Authors:  Shams Rahman; Christine M Pierce Campbell; Tim Waterboer; Dana E Rollison; Donna J Ingles; B Nelson Torres; Angelika Michel; Staci L Sudenga; Michael Pawlita; Luisa L Villa; Eduardo Lazcano Ponce; Amy R Borenstein; Wei Wang; Anna R Giuliano
Journal:  J Gen Virol       Date:  2016-10-06       Impact factor: 3.891

2.  Seroprevalence of mucosal and cutaneous human papillomavirus (HPV) types among children and adolescents in the general population in Germany.

Authors:  Anna Loenenbach; Michael Pawlita; Tim Waterboer; Thomas Harder; Christina Poethko-Müller; Michael Thamm; Raskit Lachmann; Yvonne Deleré; Ole Wichmann; Miriam Wiese-Posselt
Journal:  BMC Infect Dis       Date:  2022-01-10       Impact factor: 3.090

Review 3.  Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients.

Authors:  Ramya Chockalingam; Christopher Downing; Stephen K Tyring
Journal:  J Clin Med       Date:  2015-06-03       Impact factor: 4.241

4.  Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants.

Authors:  Margaret M Madeleine; Joseph J Carter; Lisa G Johnson; Gregory C Wipf; Connie Davis; Daniel Berg; Karen Nelson; Janet R Daling; Stephen M Schwartz; Denise A Galloway
Journal:  Cancer Med       Date:  2014-06-10       Impact factor: 4.452

5.  Cutaneous viral infections associated with ultraviolet radiation exposure.

Authors:  Yayi Zhao; Rossybelle P Amorrortu; Neil A Fenske; Basil Cherpelis; Jane L Messina; Vernon K Sondak; Anna R Giuliano; Michael J Schell; Tim Waterboer; Michael Pawlita; Sandrine McKay-Chopin; Tarik Gheit; Massimo Tommasino; Dana E Rollison
Journal:  Int J Cancer       Date:  2020-09-07       Impact factor: 7.396

6.  Natural history of cutaneous human papillomavirus (HPV) infection in men: the HIM study.

Authors:  Shalaka S Hampras; Anna R Giuliano; Hui-Yi Lin; Kate J Fisher; Martha E Abrahamsen; Bradley A Sirak; Michelle R Iannacone; Tarik Gheit; Massimo Tommasino; Dana E Rollison
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.